The unique molecular signature of TMJ as compared to the knee, demonstrates its susceptibility to osteoarthritis
- PMID: 40812964
- PMCID: PMC12355005
- DOI: 10.1016/j.job.2025.100680
The unique molecular signature of TMJ as compared to the knee, demonstrates its susceptibility to osteoarthritis
Abstract
Objectives: Osteoarthritis (OA) is a debilitating joint disease that affects millions of people worldwide, with prominent effects on the temporomandibular joints (TMJs) and knee. Despite its prevalence, TMJ-OA remains understudied. This study investigated the transcriptional signature of the TMJ compared to that of the knee and explored transcriptional differences in the medial and superficial layers of TMJ-OA.
Methods: TMJ and knee tissue samples were collected from 6-month-old C57BL/6 J mice. TMJ superficial and medial layer cartilage from goats were collected, separated, and treated with interleukin (IL)-1β. All samples were subjected to bulk RNA sequencing, followed by differential expression and gene-set enrichment analyses.
Results: A total of 4031 protein-coding genes were identified that were differentially expressed in the TMJ compared to the knee, with significant enrichment of neuronal system genes and lower enrichment of innate immune system genes. Key OA biomarkers (Mmp13, Postn, and Col1a1) were more highly expressed in the TMJ, indicating higher vulnerability to OA development. IL-1β treatment of goat TMJ chondrocytes mimicked the natural TMJ-OA-like transcriptional changes and immune responses, which are also observed in a rabbit TMJ-OA model. These results validated the in vitro goat TMJ-OA model. The IL-1β-treated goat TMJ medial cartilage layer was enriched with OA-associated transcription factors, senescence genes, and epigenetic regulators.
Conclusions: This study demonstrated the unique transcriptomic signature of the TMJ compared to that of the knee, identifying differential vulnerabilities to OA- and pain-related genes. These findings provide valuable insights into the molecular mechanisms and therapeutic target selection for TMJ-OA treatment.
Keywords: Biomarkers; Interleukin-1 beta; MMP13; Osteoarthritis; POSTN; Temporomandibular joint.
Copyright © 2025 Japanese Association for Oral Biology. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Unique TMJ-specific transcriptomic signature and its medial layer: Implications in osteoarthritis.bioRxiv [Preprint]. 2025 May 18:2025.05.18.654737. doi: 10.1101/2025.05.18.654737. bioRxiv. 2025. PMID: 40462979 Free PMC article. Preprint.
-
Human Infrapatellar Fat Pad Mesenchymal Stem Cell-derived Extracellular Vesicles Purified by Anion Exchange Chromatography Suppress Osteoarthritis Progression in a Mouse Model.Clin Orthop Relat Res. 2024 Jul 1;482(7):1246-1262. doi: 10.1097/CORR.0000000000003067. Epub 2024 Apr 19. Clin Orthop Relat Res. 2024. PMID: 38662932 Free PMC article.
-
Exercise for osteoarthritis of the knee.Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD004376. doi: 10.1002/14651858.CD004376.pub3. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2024 Dec 3;12:CD004376. doi: 10.1002/14651858.CD004376.pub4. PMID: 25569281 Free PMC article. Updated.
-
WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee.Cochrane Database Syst Rev. 2007 Jul 18;2006(1):CD000142. doi: 10.1002/14651858.CD000142.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636601 Free PMC article.
-
How Does Shame Relate to Clinical and Psychosocial Outcomes in Knee Osteoarthritis?Clin Orthop Relat Res. 2025 Apr 1;483(4):558-570. doi: 10.1097/CORR.0000000000003329. Epub 2024 Dec 3. Clin Orthop Relat Res. 2025. PMID: 39625176
References
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous